Among patients with acute LBP, use of nonpharmacologic therapy was associated with reduced risk for overdose-related hospitalizations.

Total hip BMD increases were associated with reduced risk for vertebral and all clinical fractures across active control or sequential therapy trials.

Patients with at least 5 comorbidities had worsened pain and functional scores compared with patients with 3 comorbidities at 12 months following TKA.

Oral opioid use is common among patients with SPRA, ankylosing spondylitis, and PsA and is associated with an increased risk of mortality.

Pain complaints among hospitalized patients with COVID-19 were negatively correlated with emergency intubation.

Nonbenzodiazepine MRs may improve pain, muscle spasms, and physical outcomes compared with placebo in adults with acute LBP.